Literature DB >> 9819411

Tissue-restricted expression of the cardiac alpha-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites.

M Gupta1, R Zak, T A Libermann, M P Gupta.   

Abstract

The expression of the alpha-myosin heavy chain (MHC) gene is restricted primarily to cardiac myocytes. To date, several positive regulatory elements and their binding factors involved in alpha-MHC gene regulation have been identified; however, the mechanism restricting the expression of this gene to cardiac myocytes has yet to be elucidated. In this study, we have identified by using sequential deletion mutants of the rat cardiac alpha-MHC gene a 30-bp purine-rich negative regulatory (PNR) element located in the first intronic region that appeared to be essential for the tissue-specific expression of the alpha-MHC gene. Removal of this element alone elevated (20- to 30-fold) the expression of the alpha-MHC gene in cardiac myocyte cultures and in heart muscle directly injected with plasmid DNA. Surprisingly, this deletion also allowed a significant expression of the alpha-MHC gene in HeLa and other nonmuscle cells, where it is normally inactive. The PNR element required upstream sequences of the alpha-MHC gene for negative gene regulation. By DNase I footprint analysis of the PNR element, a palindrome of two high-affinity Ets-binding sites (CTTCCCTGGAAG) was identified. Furthermore, by analyses of site-specific base-pair mutation, mobility gel shift competition, and UV cross-linking, two different Ets-like proteins from cardiac and HeLa cell nuclear extracts were found to bind to the PNR motif. Moreover, the activity of the PNR-binding factor was found to be increased two- to threefold in adult rat hearts subjected to pressure overload hypertrophy, where the alpha-MHC gene is usually suppressed. These data demonstrate that the PNR element plays a dual role, both downregulating the expression of the alpha-MHC gene in cardiac myocytes and silencing the muscle gene activity in nonmuscle cells. Similar palindromic Ets-binding motifs are found conserved in the alpha-MHC genes from different species and in other cardiac myocyte-restricted genes. These results are the first to reveal a role of the Ets class of proteins in controlling the tissue-specific expression of a cardiac muscle gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819411      PMCID: PMC109306          DOI: 10.1128/MCB.18.12.7243

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells.

Authors:  N Mori; C Schoenherr; D J Vandenbergh; D J Anderson
Journal:  Neuron       Date:  1992-07       Impact factor: 17.173

2.  cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.

Authors:  C B Thompson; C Y Wang; I C Ho; P R Bohjanen; B Petryniak; C H June; S Miesfeldt; L Zhang; G J Nabel; B Karpinski
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  cis-acting elements responsible for muscle-specific expression of the myosin heavy chain beta gene.

Authors:  N Shimizu; G Prior; P K Umeda; R Zak
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 4.  The Ets family of transcription factors.

Authors:  B Wasylyk; S L Hahn; A Giovane
Journal:  Eur J Biochem       Date:  1993-01-15

5.  Characterization and nucleotide sequence of the cardiac alpha-myosin heavy chain gene from Syrian hamster.

Authors:  R Wang; M J Sole; E Cukerman; C C Liew
Journal:  J Mol Cell Cardiol       Date:  1994-09       Impact factor: 5.000

6.  An E-box/M-CAT hybrid motif and cognate binding protein(s) regulate the basal muscle-specific and cAMP-inducible expression of the rat cardiac alpha-myosin heavy chain gene.

Authors:  M P Gupta; M Gupta; R Zak
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

7.  The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.

Authors:  C Hagemeier; A J Bannister; A Cook; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

8.  Integration of MAP kinase signal transduction pathways at the serum response element.

Authors:  A J Whitmarsh; P Shore; A D Sharrocks; R J Davis
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

9.  Identification of a contractile-responsive element in the cardiac alpha-myosin heavy chain gene.

Authors:  K Ojamaa; A M Samarel; I Klein
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

10.  Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET).

Authors:  M A Price; A E Rogers; R Treisman
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

View more
  11 in total

1.  Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription.

Authors:  S Muangmingsuk; P Ingram; M P Gupta; R A Arcilla; M Gupta
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

2.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

3.  Role of cyclic AMP-dependent kinase response element-binding protein in recombinant adeno-associated virus-mediated transduction of heart muscle cells.

Authors:  Jarrod Dean; Jeremy Plante; Gordon S Huggins; Richard O Snyder; Ryuichi Aikawa
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

Review 4.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

Review 5.  Strategies to achieve conditional gene mutation in mice.

Authors:  Jessica J Gierut; Tyler E Jacks; Kevin M Haigis
Journal:  Cold Spring Harb Protoc       Date:  2014-04-01

6.  Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

Authors:  Rajesha Rupaimoole; Sherry Y Wu; Sunila Pradeep; Cristina Ivan; Chad V Pecot; Kshipra M Gharpure; Archana S Nagaraja; Guillermo N Armaiz-Pena; Michael McGuire; Behrouz Zand; Heather J Dalton; Justyna Filant; Justin Bottsford Miller; Chunhua Lu; Nouara C Sadaoui; Lingegowda S Mangala; Morgan Taylor; Twan van den Beucken; Elizabeth Koch; Cristian Rodriguez-Aguayo; Li Huang; Menashe Bar-Eli; Bradly G Wouters; Milan Radovich; Mircea Ivan; George A Calin; Wei Zhang; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Nat Commun       Date:  2014-10-29       Impact factor: 14.919

7.  Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.

Authors:  Shan Xing; Zhi Tian; Wenying Zheng; Wenjuan Yang; Nan Du; Yixue Gu; Jiang Yin; Hao Liu; Xiaoting Jia; Donglan Huang; Wanli Liu; Min Deng
Journal:  Mol Cancer       Date:  2021-01-06       Impact factor: 27.401

8.  Silencer-delimited transgenesis: NRSE/RE1 sequences promote neural-specific transgene expression in a NRSF/REST-dependent manner.

Authors:  Xiayang Xie; Jonathan R Mathias; Marie-Ange Smith; Steven L Walker; Yong Teng; Martin Distel; Reinhard W Köster; Howard I Sirotkin; Meera T Saxena; Jeff S Mumm
Journal:  BMC Biol       Date:  2012-11-30       Impact factor: 7.431

9.  Functional validation of a constitutive autonomous silencer element.

Authors:  Heyuan Qi; Mingdong Liu; David W Emery; George Stamatoyannopoulos
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

10.  Modeling the integration of bacterial rRNA fragments into the human cancer genome.

Authors:  Karsten B Sieber; Pawel Gajer; Julie C Dunning Hotopp
Journal:  BMC Bioinformatics       Date:  2016-03-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.